Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FASN-IN-5
Cat. No.:
OB0425LY-149
Appearance:
Solid
Purity:
99.81%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
FASN-IN-5 is a specific inhibitor of fatty acid synthase (FAS) with potential anti-tumor and anti-obesity effects.
Synonyms:
1309805-49-9; Methanone, [(3S)-3-[[2-[4-(5-benzofuranyl)phenyl]-1H-imidazo[4,5-c]pyridin-1-yl]methyl]-1-pyrrolidinyl]cyclopropyl-; [(3S)-3-[[2-[4-(1-Benzofuran-5-yl)phenyl]imidazo[4,5-c]pyridin-1-yl]methyl]pyrrolidin-1-yl]-cyclopropylmethanone; 2-[4-(1-Benzo furan-5-yl)phenyl]-1-{[(3S)-1-(cyclopropylcarbonyl)-3-pyrrolidinyl]methyl}-1H-imidazo[4,5-c]pyridine
CAS No.:
1309805-49-9
Compound CID:
57519543
Formula:
C29H26N4O2
Formula Weight:
462.54
Specification
Target:
Fatty acid synthase (FASN)
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Characteristics:
Enantiomeric excess: 98.97%
Storage:
Storage at -20°C.
Applications:
FASN-IN-5 can be used to study obesity-related cancer cell metabolism and the role of FAS in obesity tumor biology.
